John STRANG,Alexander OKSCHE,Stephen HARRIS,Kevin SMITH,Lucie Helene Jeanne MOTTIER
申请号：
US15590466
公开号：
US20170304192A1
申请日:
2017.05.09
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to an intranasal pharmaceutical dosage form comprising a dosing unit comprising naloxone or a pharmaceutically acceptable salt thereof in an amount of equivalent to ≧0.5 mg naloxone HCl dissolved in an application fluid of a volume of ≦250 μl. Furthermore, the present invention relates to such an intranasal pharmaceutical dosage form for use in the treatment of opioid overdosing and/or at least one symptom thereof.
